Terms: = Leukemia AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Prognosis
9 results:
1. Prognostic Impact of Bone Marrow Fibrosis and Effects of Tyrosine Kinase Inhibitors on Bone Marrow Fibrosis in Chronic Myeloid leukemia.
Pepeler MS; Tıglıoglu M; Dagdas S; Ozhamamcıoglu E; Han U; Albayrak A; Aydın MS; Korkmaz G; Pamukcuoğlu M; Ceran F; Albayrak M; Ozet G
Clin Lymphoma Myeloma Leuk; 2024 Apr; 24(4):e161-e167. PubMed ID: 38342726
[TBL] [Abstract] [Full Text] [Related]
2. [Clinical characteristics and prognostic analysis of pediatric pro-B cell acute lymphoblastic leukemia].
Xue YJ; Lu AD; Wang Y; Jia YP; Zuo YX; Zhang LP
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Dec; 22(12):1286-1294. PubMed ID: 33327999
[TBL] [Abstract] [Full Text] [Related]
3. Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of Myelofibrosis.
Pastor-Galán I; Hernández-Boluda JC; Correa JG; Alvarez-Larrán A; Ferrer-Marín F; Raya JM; Ayala R; Velez P; Pérez-Encinas M; Estrada N; García-Gutiérrez V; Fox ML; Payer A; Kerguelen A; Cuevas B; Durán MA; Ramírez MJ; Gómez-Casares MT; Mata-Vázquez MI; Mora E; Martínez-Valverde C; Arbelo E; Angona A; Magro E; Antelo ML; Somolinos N; Cervantes F;
Med Clin (Barc); 2020 Aug; 155(4):152-158. PubMed ID: 31980217
[TBL] [Abstract] [Full Text] [Related]
4. [Analysis of induction efficacy and prognostic factors in FLT3-ITD positive acute myeloid leukemia in the real world].
Jia JS; Zhu HH; Gong LZ; Zhao T; Wang J; Jiang Q; Huang XJ; Jiang H
Zhonghua Xue Ye Xue Za Zhi; 2019 May; 40(5):398-403. PubMed ID: 31207705
[No Abstract] [Full Text] [Related]
5. [Prognostic Significance of Joint Detection of miR-210 and Minimal Residual Disease in Pediatric Acute Lymphoblastic leukemia].
Mei YY; Li ZG; Zhang Y; Zhang WL; Zhang PW; Wang N; Huang DS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):66-71. PubMed ID: 28245377
[TBL] [Abstract] [Full Text] [Related]
6. Chronic eosinophilic leukemia-not otherwise specified has a poor prognosis with unresponsiveness to conventional treatment and high risk of acute transformation.
Helbig G; Soja A; Bartkowska-Chrobok A; Kyrcz-Krzemień S
Am J Hematol; 2012 Jun; 87(6):643-5. PubMed ID: 22473587
[TBL] [Abstract] [Full Text] [Related]
7. Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients.
Dufour A; Schneider F; Hoster E; Benthaus T; Ksienzyk B; Schneider S; Kakadia PM; Sauerland MC; Berdel WE; Büchner T; Wörmann B; Braess J; Subklewe M; Hiddemann W; Bohlander SK; Spiekermann K;
Ann Hematol; 2012 Jul; 91(7):1051-63. PubMed ID: 22362118
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic significance of glucocorticoid receptor determination in patients with chronic lymphocytic leukemia and immunocytoma--lack of a positive correlation between receptor levels and clinical responsiveness.
Weiss C; Ho AD; Hiller E; Thiel E; Schlag R; Lipp T; Herrmann R; Musch E; Termander B; Hunstein W
Leuk Res; 1990; 14(4):327-32. PubMed ID: 2332986
[TBL] [Abstract] [Full Text] [Related]
9. [Protocols for the treatment of leukemia and lymphoma: toward escalation or toward reduction of degree?].
Mathé G; Misset JL; Machover D; Schwarzenberg L; Timus M; Jasmin C; Ribaud P; Musset M
Biomed Pharmacother; 1984; 38(1):13-32. PubMed ID: 6380605
[TBL] [Abstract] [Full Text] [Related]
